Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Chongqing Medical UniversityNo recent work listed

Zhu Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0274-8007; OpenAlex author ID A5100374213. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. HTR1D functions as a key target of HOXA10-AS/miR-340-3p axis to promote the malignant outcome of pancreatic cancer via PI3K-AKT signaling pathway. Co-author DOI 10.7150/ijbs.70546↗
  2. Mutations in the p16 gene in DMBA-induced pancreatic intraepithelial neoplasia and pancreatic cancer in rats. Co-author DOI 10.1016/s1499-3872(15)60331-9↗
  3. Expression of CD44, CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment. Co-author DOI 10.1016/s1499-3872(11)60073-8↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wu Wu · 1 shared paper, 2022 · strength 0.15
  2. Jianping Gong · 1 shared paper, 2022 · strength 0.15
  3. Yan Liu · 1 shared paper, 2022 · strength 0.15
  4. Menghao Wang · 1 shared paper, 2022 · strength 0.15
  5. Chunyou Wang · 2 shared papers, 2011–2015 · strength 0.10
  6. Fei Han · 1 shared paper, 2015 · strength 0.06
  7. Tao Yin · 1 shared paper, 2011 · strength 0.03
  8. Pengfei Shi · 1 shared paper, 2011 · strength 0.03
  9. Yuan Tian · 1 shared paper, 2011 · strength 0.03
  10. Hong-Ji Wei · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.